Ruff, M. W., Buckner, J. C., Johnson, D. R., van den Bent, M. J., & Geurts, M. (2019). Neuro-Oncology Clinical Debate: PCV or temozolomide in combination with radiation for newly diagnosed high-grade oligodendroglioma. Neurooncol Pract.
Citação norma ChicagoRuff, Michael W., Jan C. Buckner, Derek R. Johnson, Martin J. van den Bent, and Marjolein Geurts. "Neuro-Oncology Clinical Debate: PCV or Temozolomide in Combination With Radiation for Newly Diagnosed High-grade Oligodendroglioma." Neurooncol Pract 2019.
Citação norma MLARuff, Michael W., et al. "Neuro-Oncology Clinical Debate: PCV or Temozolomide in Combination With Radiation for Newly Diagnosed High-grade Oligodendroglioma." Neurooncol Pract 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.